Normal view MARC view ISBD view

Immunotherapy: Response to nivolumab in RCC: RECISTing progression.

Sidaway, Peter

Immunotherapy: Response to nivolumab in RCC: RECISTing progression. [electronic resource] - Nature reviews. Clinical oncology 07 2016 - 396-7 p. digital

Publication Type: Journal Article; Comment

ISSN: 1759-4782

Standard No.: 10.1038/nrclinonc.2016.93 doi

Subjects--Topical Terms:
Antibodies, Monoclonal
Humans
Immunotherapy
Nivolumab

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)